Last reviewed · How we verify

NCT06754657: CORA-Q15

CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery

Recruiting now Phase 4 Last updated 30 May 2025
What this trial tests

Phase 4 trial testing Continuous perineural infusion in Arthropathy Shoulder in 150 participants. Currently enrolling.

Timeline
26 May 2025
Primary endpoint
31 December 2026
31 March 2027

Quick facts

Lead sponsorPontificia Universidad Catolica de Chile
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment150
Start date26 May 2025
Primary completion31 December 2026
Estimated completion31 March 2027
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Pontificia Universidad Catolica de Chile — full company profile →

Who can join

Adults 18 to 75, any sex, with Arthropathy Shoulder or Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery. The participants will: * Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthropathy Shoulder

Currently open trials in the same condition.

Other Pontificia Universidad Catolica de Chile trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06754657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing